|IDT Australia Limited|
45 Wadhurst Drive
Australia - Map
Phone: 61 3 9801 8888
Fax: 61 3 9801 8773
IDT Australia Limited provides products, research and development, and other technical services for the pharmaceutical and allied industries in Australia. It is involved in the development, scale-up, and manufacture of high potency and cytotoxic API, and finished drug products. The company develops cytotoxics, anti-cancer drugs, anti-psychotics, antibiotics, beta lactams, and controlled drugs. It also offers various specialist clinical trial labelling, packaging, and dispensing services; and clinical trials research and pharmacy services in a range of therapeutic areas. In addition, the company manufactures active and placebo clinical trial supplies in various dosage forms, such as tablets, coated tablets, capsules, suspensions, liquids, sprays, patches, lyophilised powders, and ointments. Further, it offers analytical services, such as method validation/verification, compendial testing, stability testing, microbiology testing, cleaning validation, identity testing, assembly, related substances, residual solvents, limit testing, melting point, clarity, gravimetric, viscosity, dissolution, dosage uniformity, hardness/friability/disintegration, and chemical monitoring services. IDT Australia Limited is headquartered in Boronia, Australia.
|Dr. Paul Donald Richard MacLeman BVSc, MBA, Grad Dip Tech Mgt, Grad Cert Eng,FAICD,
Chief Exec. Officer, Managing Director and Director
|Dr. Graeme L. Blackman OAM, BSc (Hons), Ph.D., FRACI, FTSE,
Founder, Director and Member of Nomination & Remuneration Committee
|Ms. Joanna Johnson ,
Chief Financial Officer and Company Sec.
|Dr. David Sparling ,
VP of Legal & Corp. Devel. and Joint Sec.
|Mr. Mark Rowlands ,
VP of Bus. Devel. & Marketing
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in AUD.|